Is Puma Biotechnology, Inc. overvalued?

Puma Biotechnology, Inc. (PBYI) looks overvalued — trading about 26% above its fair value.

Overvalued

Price

$7.77

Fair value

$5.77

Current P/E

12.7

Normal P/E

9.5

Market cap

$401.7M

Dividend yield

0.0%

Return on equity

17.5%

Sector

Healthcare

Fair value compares PBYI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks